SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

HC Wainwright & Co. Reiterates Buy on KemPharm, Lowers Price Target to $1.5

HC Wainwright & Co. reiterates KemPharm (NASDAQ:KMPH) with a Buy and lowers the price target from $2.5 to $1.5.

Benzinga · 05/20/2020 10:59

HC Wainwright & Co. reiterates KemPharm (NASDAQ:KMPH) with a Buy and lowers the price target from $2.5 to $1.5.